Lisata Therapeutics Inc - Company Profile

Powered by

All the sales intelligence you need on Lisata Therapeutics Inc in one solution.

$195 $295
Register your interest Learn more
  • Save hours of research time with a comprehensive
    Sales Intelligence Solution.

  • Understand how Lisata Therapeutics Inc fits into your total
    addressable market and Ideal Customer Profile.

  • Gain competitive edge with triggers that tell you
    when and how to engage with Lisata Therapeutics Inc.

Back to companies

Lisata Therapeutics Inc: Patents

Get in touch about GlobalData Company reports

Contact the team or request a demo to find out how our data can drive your business forward

Select Item

View up-to-date information on Lisata Therapeutics Inc patents, including inventor and filing insights.

Patent Trends

Publication Identifier Document Type Title Classification-CPC Publication Date
AU2022270659A1 Application Irgd-analogs and related therapeutic methods A61K31/282; A61K31/337; A61K31/4745; A61K31/505; A61K31/513; A61K31/519; A61K31/555; A61K31/7068; A61K38/12; A61K38/17; A61K45/06; A61K47/12; A61K47/26; A61K47/643; A61K47/6929; A61K9/0019; A61K9/19; A61P35/00; C07K16/2863 November 30, 2023
CA3217749A1 Application Irgd-analogs and related therapeutic methods A61K31/282; A61K31/337; A61K31/4745; A61K31/505; A61K31/513; A61K31/519; A61K31/555; A61K31/7068; A61K38/12; A61K38/17; A61K45/06; A61K47/12; A61K47/26; A61K47/643; A61K47/6929; A61K9/0019; A61K9/19; A61P35/00; C07K16/2863 November 10, 2022
WO2022235852A1 Application Irgd-analogs and related therapeutic methods A61K31/282; A61K31/337; A61K31/4745; A61K31/505; A61K31/513; A61K31/519; A61K31/555; A61K31/7068; A61K38/12; A61K38/17; A61K45/06; A61K47/12; A61K47/26; A61K47/643; A61K47/6929; A61K9/0019; A61K9/19; A61P35/00; C07K16/2863 November 10, 2022
US20220023345A1 Application Compositions comprising cd34+ cells and methods for repairing a lung injury after severe virus infection A61K35/15; A61K35/16; A61K35/17; A61K9/0019; A61P11/00; A61P31/14 January 27, 2022
CN113795271A Application Low-dose cytokine co-administered with irgd for treating cancer A61K2300/00; A61K38/12; A61K38/2013; A61P35/00 December 14, 2021
Gain a 360-degree view of and make more informed decisions for your business Gain a 360-degree view of and make more informed decisions for your business Learn more

Top Inventors by Filings (Count by publication)

Name Count
Identify the top inventors associated with your target company when you unlock full profile Identify the top inventors associated with your target company when you unlock full profile Learn more
Still looking?

Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.

Explorer

Access more premium companies when you subscribe to Explorer